RTW Investments’s Akero Therapeutics AKRO Stock Holding History

RTW Investments’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,477,561	Closed	-$260M	–	93
2025 Q3	$260M	Hold	5,477,561	–	–	3.2%	8
2025 Q2	$292M	Sell	5,477,561 -1,941,779	-26%	-$88.2M	4.16%	7
2025 Q1	$300M	Buy	7,419,340 +559,517	+8%	+$23.7M	4.59%	6
2024 Q4	$191M	Buy	6,859,823 +940,388	+16%	+$28.5M	2.89%	13
2024 Q3	$170M	Buy	5,919,435 +487,450	+9%	+$12.7M	2.46%	17
2024 Q2	$127M	Hold	5,431,985	–	–	1.97%	20
2024 Q1	$137M	Buy	5,431,985 +1,839,226	+51%	+$44.2M	2.03%	19
2023 Q4	$83.9M	Buy	+3,592,759	New	+$70.9M	1.31%	25

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

RTW Investments's AKRO Position: Q4 2025 in Review

RTW Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 5,477,561 shares — an estimated $260M sold.

RTW Investments first reported a position in AKRO in Q4 2023 and held it in 8 quarters. The position peaked at $300M in Q1 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

RTW Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
RTW Investments sold 5,477,561 Akero Therapeutics shares in Q4 2025, an estimated $260M.
RTW Investments first reported a position in Akero Therapeutics in Q4 2023 and held it in 8 quarters.
RTW Investments's Akero Therapeutics position peaked at $300M in Q1 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on RTW Investments's 13F filing for Q4 2025, filed 17 Feb 2026.